• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celyad Oncology SA - American Depositary Shares (NQ:CYAD)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Celyad Oncology SA - American Depositary Shares

News headline image
Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
September 07, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
September 05, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights
September 04, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
August 24, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology announces receipt of Nasdaq delisting notice
May 15, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq
May 05, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology reports first quarter 2023 financial results and recent business highlights
May 05, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price
April 24, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology announces receipt of Nasdaq notice
April 04, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology appoints Georges Rawadi as its new CEO
March 24, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology reports full year 2022 financial results and recent business highlights
March 23, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology to announce full year 2022 financial results and host conference call
March 17, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology announces non-cash impairment
March 15, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
REPEAT -- Celyad Oncology SA - Letter to Shareholders
March 01, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology SA - Letter to Shareholders
February 28, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01
February 09, 2023
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
February 03, 2023
From Celyad Oncology SA
Via GlobeNewswire
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
January 19, 2023
EQNX::TICKER_START (NASDAQ:TCBP),(NASDAQ:CRDF),(NASDAQ:CYAD),(NASDAQ:RIGL),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property
December 21, 2022
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights
November 10, 2022
From Celyad Oncology SA
Via GlobeNewswire
News headline image
Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction
September 20, 2022
From Cellistic
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap